SCHEME 1. Classical Route to Benzofuropyrazoles
An Efficient Intramolecular 1,3-Dipolar
Cycloaddition Involving
2-(1,2-Dichlorovinyloxy)aryldiazomethanes: A
One-Pot Synthesis of Benzofuropyrazoles from
Salicylaldehydes
zothieno- and benzofuropyrazolyl compounds have also been
identified as modulators of the 5HT2c receptor. Potentially
treatable disorders associated with this receptor are obesity,
eating disorders, and obesity-related diabetes.4 New synthetic
methods that allow efficient access to this class of fused
heterocycles is therefore of great value especially in the early
stages of drug discovery and structure-activity studies. We wish
to report herein an efficient intramolecular dipolar cycloaddition
strategy for a rapid, one-pot assembly of benzofuropyrazoles
starting from the corresponding salicylaldehydes.
Zachary S. Sales and Neelakandha S. Mani*
Johnson & Johnson Pharmaceutical Research and
DeVelopment, L.L.C., 3210 Merryfield Row,
San Diego, California 92121
ReceiVed October 03, 2008
Despite their gaining prominence, preparation of this class
of fused pyrazoles has relied mostly on the Knorr pyrazole
synthesis involving the condensation of a 1,3-dicarbonyl
substrate with hydrazine5 (Scheme 1).
This condensation involving an acylbenzofuranone is not
always very efficient due to other competing reaction pathways
such as deacylation and ring opening.5 In our experience, these
side reactions appear to be particularly dominant in the case of
those acylbenzofuranones that contain electron-donating sub-
stituents on the aromatic ring. These difficulties prompted us
to explore novel disconnections that might be more efficient.
1,3-Dipolar cycloaddition of nitrile imines or diazo compounds
with olefinic or acetylenic dipolarophiles has been reported to
offer an alternative method to construct pyrazoles.6 Kirmse and
Dietrich7 have reported that 2-(allyloxy)phenyldiazomethane
undergoes intramolecular 1,3-dipolar cycloaddition to form a
fused benzopyranopyrazoline derivative. Subsequently, Padwa
and Ku8 showed that thermolysis of a 2-(2- alkenyl)phenyldia-
zomethane gave tetrahydroindenopyrazole cycloadduct in high
yields. More recently, Aggarwal9 and Chandrasekharan10 have
reported cycloaddition of aryldiazomethanes with dipolarophiles
in which they describe a safe, in situ generation of aryldiaz-
omethanes by the base-mediated decomposition of tosylhydra-
zones under mild conditions. We thus envisaged an intramo-
lecular 1,3-dipolar cycloaddition involving an in situ generated
2-(vinyloxy)aryldiazomethane 3 as outlined in Scheme 2. The
initial pyrazoline adduct 4 was then proposed to be aromatized
A novel intramolecular 1,3-dipolar cycloaddition strategy for
a rapid entry into benzofuropyrazoles is described. In a three-
step
sequence,
(E)-2-(1,2-dichlorovinyloxy)aryldiaz-
omethanes were generated in situ from the corresponding
salicylaldehydes. Intramolecular cycloaddition followed by
dehydrohalogenation garnered 3-chlorobenzofuropyrazoles
in excellent yields. By careful choice of solvent, base, and
reaction conditions, the entire sequence can be carried out
in a one-pot procedure.
Fused pyrazoles such as benzofuropyrazoles are structural
motifs increasingly found in a wide array of medicinal chemistry
programs. For example, 1H-benzofuro[3,2]pyrazolyl-3-amine
derivatives have been reported to have analgesic and anticon-
vulsant properties due to their ability to inhibit selectively the
cyclooxygenase 2 (COX 2) enzyme.1 A class of 3-arylbenzo-
furopyrazoles has been developed as inhibitors of certain
tyrosine kinases for the treatment of diseases and disorders
associated with abnormal cell proliferation.2 Fused pyrazoles,
including benzothieno- and benzofuropyrazoles, have been
identified as selective histamine H3 antagonists, which are
potentially useful in the treatment of a host of CNS disorders
such as ADHD, Parkinson’s disease, memory, Alzheimer’s,
narcolepsy, sleep apnea, insomnia, etc.3 A number of ben-
(4) Ladoucur, G. H.; Choi, S.; Wang, Y. WO 2003/057161, A2 PCT/US02/
41859.
(5) (a) Mosher, W. A.; Serridge, P. M.; Lipp, D. W. J. Org. Chem. 1972,
37, 2402–2405. (b) Gatta, F.; Settimj, G. J. Heterocycl. Chem. 1984, 21, 937–
943.
(6) (a) Padwa, A. 1,3-Dipolar Cycloaddition Chemistry; John Wiley & Sons:
New York, 1984; Vol. 1. (b) Regitz, M.; Maas, G. Diazo Compounds: Properties
and Synthesis; Academic Press: London, 1996. (c) Maas, G. In Synthetic
Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and
Natural Products; Padwa, A., Taylor, E. C., Pearson, W. H., Eds.; John Wiley
& Sons: New York, 2002.
(7) Kirmse, W.; Dietrich, H. Chem. Ber. 1967, 100, 2710–2718.
(8) Padwa, A.; Ku, H. J. Org. Chem. 1980, 45, 3756–3766. We are grateful
to the reviewers for bringing the earlier works of Kirmse and Padwa to our
attention.
(1) (a) Philipp, A.; Jirkowsky, I.; Martel, R. US Patent 4420,476 (December
1983), Appl. No 380,973. (b) Talley, J.; Stephen, R. WO 96/09304, PCT/US
95/11403. (c) Caruso, F. S. WO 00/29023, PCT/US 98/24317.
(2) (a) Murata, K.; Kumagai, H.; Kawashima, T.; Tamitsu, K.; Irie, M.;
Nakajima, H.; Suzu, S.; Shibuya, M.; Kamihira, S.; Nosaka, T.; Asano, S.;
Kitamura, T. J. Biol. Chem. 2003, 278, 32892–32898. (b) Donald, S.; Whartenby,
K.; Pardoll, D. WO 2006/020145, PCT/US 2005/025318and references cited
therein.
(9) Aggarwal, V. K.; de Vicente, J.; Bonnert, R. V. J. Org. Chem. 2003, 68,
5381–5383.
(3) Bennani, Y. L.; Campbell, M. G.; Dastrup, D.; Porterhuck, E. WO 2007/
094962, A2 PCT/US2007/002547.
(10) Chandrasekhar, S.; Rajaiah, G.; Srihari, P. Tetrahedron Lett. 2001, 42,
6599–6601.
10.1021/jo802193z CCC: $40.75
Published on Web 12/03/2008
2009 American Chemical Society
J. Org. Chem. 2009, 74, 891–894 891